fda compounding semaglutide warning september 2025 Drug Recalls and Warnings: Recalls for Compounded and Tirzepatide, Wegovy; Facility Letters September 2, 2025: U.S. compounding

Nevertheless, understanding GI adverse events across both earlier and newer GLP-1based therapies remains highly relevant, particularly as these agents are increasingly prescribed for long-term and off-label indications

Best Practices for a Comfortable and Safe Experience These tips can help make injections more comfortable and reduce potential issues

However, there are major differences between these medications, including how they affect your body and how long you should use them

Again, though, prospective GLP-1 users should discuss health and safety concerns with their doctor

Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men

Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss